Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Quince Therapeutics, Inc. (QNCX) operates as a biopharmaceutical firm dedicated to developing targeted treatments for debilitating and rare diseases.

52W Range

2ndpctl

Volume

0.48×avg

Market Cap

9.40MUSD

P/E Ratio

-0.5TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Quince Therapeutics, Inc.

QNCXNASDAQ Global Select·USD·Closed

Quince Therapeutics, Inc.

QNCXNASDAQ·USD·Closed

$33.75

+3.85%

$33.75

+$1.25 (3.85%)

52W Range

2ndpctl

Volume

0.48×avg

Mkt Cap

9.40MUSD

P/E

-0.5TTM

Div Yield

–ann

QNCX: Quince Therapeutics, Inc. Stock Analysis | finqOS